A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism

Authors:

Abstract
Mn-PyC3A is a newly developed manganese-based MR imaging contrast agent that produces comparable MR angiographic contrast enhancement to the commercially available gadolinium-based contrast agent gadopentetate dimeglumine in a baboon model at 3.0 T, is cleared via a mixed renal and hepatobiliary pathway, and is rapidly excreted without any observable metabolism. PurposeTo compare intravascular contrast enhancement produced by the manganese-based magnetic resonance (MR) imaging contrast agent manganese-N-picolyl-N,N’,N’-trans-1,2-cyclohexenediaminetriacetate (Mn-PyC3A) to gadopentetate dimeglumine (Gd-DTPA) and to evaluate the excretion, pharmacokinetics, and metabolism of Mn-PyC3A.Materials and MethodsContrast material–enhanced MR angiography was performed in baboons (Papio anubis; n = 4) by using Mn-PyC3A and Gd-DTPA. Dynamic imaging was performed for 60 minutes following Mn-PyC3A injection to monitor distribution and elimination. Serial blood sampling was performed to quantify manganese and gadolinium plasma clearance by using inductively coupled plasma mass spectrometry and to characterize Mn-PyC3A metabolism by using high-performance liquid chromatography. Intravascular contrast enhancement in the abdominal aorta and brachiocephalic artery was quantified by measuring contrast-to-noise ratios (CNRs) versus muscle at 9 seconds following Mn-PyC3A or Gd-DTPA inje...
Funding Information
  • National Center for Research Resources (P41RR14075, S10RR023385)
  • National Heart, Lung, and Blood Institute (K25HL128899, U54HL119145)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB009062, R21EB022804)
  • National Institutes of Health Office of the Director (S10OD010650)

This publication has 31 references indexed in Scilit: